Infection & Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, Australia.
PLoS One. 2020 Apr 1;15(4):e0231041. doi: 10.1371/journal.pone.0231041. eCollection 2020.
This study describes predictors of pneumococcal nasopharyngeal carriage and density in Fiji. We used data from four annual (2012-2015) cross-sectional surveys, pre- and post-introduction of ten-valent pneumococcal conjugate vaccine (PCV10) in October 2012. Infants (5-8 weeks), toddlers (12-23 months), children (2-6 years), and their caregivers participated. Pneumococci were detected and quantified using lytA qPCR, with molecular serotyping by microarray. Logistic and quantile regression were used to determine predictors of pneumococcal carriage and density, respectively. There were 8,109 participants. Pneumococcal carriage was negatively associated with years post-PCV10 introduction (global P<0.001), and positively associated with indigenous iTaukei ethnicity (aOR 2.74 [95% CI 2.17-3.45] P<0.001); young age (infant, toddler, and child compared with caregiver participant groups) (global P<0.001); urban residence (aOR 1.45 [95% CI 1.30-2.57] P<0.001); living with ≥2 children <5 years of age (aOR 1.42 [95% CI 1.27-1.59] P<0.001); low family income (aOR 1.44 [95% CI 1.28-1.62] P<0.001); and upper respiratory tract infection (URTI) symptoms (aOR 1.77 [95% CI 1.57-2.01] P<0.001). Predictors were similar for PCV10 and non-PCV10 carriage, except PCV10 carriage was negatively associated with PCV10 vaccination (0.58 [95% CI 0.41-0.82] P = 0.002) and positively associated with exposure to household cigarette smoke (aOR 1.21 [95% CI 1.02-1.43] P = 0.031), while there was no association between years post-PCV10 introduction and non-PCV10 carriage. Pneumococcal density was positively associated with URTI symptoms (adjusted median difference 0.28 [95% CI 0.16, 0.40] P<0.001) and toddler and child, compared with caregiver, participant groups (global P = 0.008). Predictors were similar for PCV10 and non-PCV10 density, except infant, toddler, and child participant groups were not associated with PCV10 density. PCV10 introduction was associated with reduced the odds of overall and PCV10 pneumococcal carriage in Fiji. However, after adjustment iTaukei ethnicity was positively associated with pneumococcal carriage compared with Fijians of Indian Descent, despite similar PCV10 coverage rates.
本研究描述了斐济肺炎球菌鼻咽携带和密度的预测因素。我们使用了四项年度(2012-2015 年)横断面调查的数据,这些数据是在 2012 年 10 月引入 10 价肺炎球菌结合疫苗(PCV10)之前和之后收集的。参与者包括 5-8 周的婴儿、12-23 个月的幼儿、2-6 岁的儿童及其照顾者。使用 lytA qPCR 检测和定量肺炎球菌,通过微阵列进行分子血清分型。使用逻辑回归和分位数回归分别确定肺炎球菌携带和密度的预测因素。共有 8109 名参与者。肺炎球菌携带与 PCV10 引入后时间呈负相关(全球 P<0.001),与土着伊塔基族(aOR 2.74 [95%CI 2.17-3.45] P<0.001)呈正相关;年龄较小(婴儿、幼儿和儿童与照顾者参与者组相比)(全球 P<0.001);城市居住(aOR 1.45 [95%CI 1.30-2.57] P<0.001);与≥2 名 5 岁以下儿童同住(aOR 1.42 [95%CI 1.27-1.59] P<0.001);家庭收入低(aOR 1.44 [95%CI 1.28-1.62] P<0.001);上呼吸道感染(URTI)症状(aOR 1.77 [95%CI 1.57-2.01] P<0.001)。PCV10 和非 PCV10 携带的预测因素相似,除了 PCV10 携带与 PCV10 疫苗接种呈负相关(0.58 [95%CI 0.41-0.82] P = 0.002),与家庭香烟暴露呈正相关(aOR 1.21 [95%CI 1.02-1.43] P = 0.031),而 PCV10 引入后时间与非 PCV10 携带之间没有关联。肺炎球菌密度与 URTI 症状呈正相关(调整后的中位数差异 0.28 [95%CI 0.16, 0.40] P<0.001),幼儿和儿童与照顾者参与者组相比(全球 P = 0.008)。PCV10 和非 PCV10 密度的预测因素相似,除了婴儿、幼儿和儿童参与者组与 PCV10 密度无关。PCV10 的引入与降低了斐济的整体和 PCV10 肺炎球菌携带的几率。然而,调整后,伊塔基族与印度裔斐济人相比,与肺炎球菌携带呈正相关,尽管 PCV10 覆盖率相似。